COVID-19 and harm reduction programme implementation: sharing experiences in practice - webinar #1
Paris Médecins du Monde 2020Description: Webinar 1.16.29Subject(s): Online resources: Summary: The aim of this webinar is to facilitate an interactive discussion and share experiences on how to maintain and adapt harm reduction services during the COVID-19 pandemic. Speakers will discuss: - The impact of COVID-19 on the lives of people who use drugs and their use of services - Community mobilisation and advocacy by people who use drugs - Examples of how harm reduction programmes such as OST and NSP are continued in some countries. Related terms: coronavirus, opioid agonist therapy, OAT, opioid replacement therapy, Methodone, Suboxone, BuprenorpheneItem type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Online video | Library Online | Available |
English
The aim of this webinar is to facilitate an interactive discussion and share experiences on how to maintain and adapt harm reduction services during the COVID-19 pandemic. Speakers will discuss:
- The impact of COVID-19 on the lives of people who use drugs and their use of services
- Community mobilisation and advocacy by people who use drugs
- Examples of how harm reduction programmes such as OST and NSP are continued in some countries.
Related terms: coronavirus, opioid agonist therapy, OAT, opioid replacement therapy, Methodone, Suboxone, Buprenorphene